Preoperative Dual Immunotherapy Shows Promise in High-Risk Early HER2-Negative Breast Cancer
WASHINGTON — A combination of two immunotherapy drugs produced substantially higher rates of tumor eradication when added to chemotherapy before ...
WASHINGTON — A combination of two immunotherapy drugs produced substantially higher rates of tumor eradication when added to chemotherapy before ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine